Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial
Authors
Keywords
Personalized medicine, Biomarkers, Pentaglobin, IgGAM, Sepsis, Peritonitis, Severe bacterial infection
Journal
Trials
Volume 20, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-04
DOI
10.1186/s13063-019-3244-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
- (2016) Evelien de Jong et al. LANCET INFECTIOUS DISEASES
- Pathophysiologie der Peritonitis
- (2015) K. Beyer et al. CHIRURG
- Intra-abdominal candidiasis: it’s still a long way to get unquestionable data
- (2015) Philippe Montravers et al. INTENSIVE CARE MEDICINE
- Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study
- (2015) Alessandro Neri et al. International Journal of Surgery
- Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome
- (2014) Jan De Waele et al. BMC INFECTIOUS DISEASES
- Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock
- (2014) Ilaria Cavazzuti et al. INTENSIVE CARE MEDICINE
- Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis
- (2014) J. F. Bermejo-Martín et al. JOURNAL OF INTERNAL MEDICINE
- Immunopathogenesis of abdominal sepsis
- (2014) Georg F. Weber et al. LANGENBECKS ARCHIVES OF SURGERY
- Early levels in blood of immunoglobulin M and natural killer cells predict outcome in nonseptic critically ill patients
- (2013) David Andaluz-Ojeda et al. JOURNAL OF CRITICAL CARE
- Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock
- (2012) Eduardo Tamayo et al. JOURNAL OF CRITICAL CARE
- Aquaporin 5 Gene Promoter −1364A/C Polymorphism Associated with 30-day Survival in Severe Sepsis
- (2011) Michael Adamzik et al. ANESTHESIOLOGY
- A Single Nucleotide Polymorphism in NF- B Inducing Kinase Is Associated with Mortality in Septic Shock
- (2011) S. A. Thair et al. JOURNAL OF IMMUNOLOGY
- Endothelial Nitric Oxide Synthase 894G→T But Not −786T→C Gene Polymorphism Is Associated With Organ Dysfunction and Increased Mortality in Patients With Severe Sepsis
- (2011) Penglin Ma et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Granulocyte–Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression
- (2009) Christian Meisel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sepsismarker – was ist sinnvoll?
- (2008) F Brunkhorst DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started